GlassScriptPhysician profile
Sarah E Sutnick
NPI 1023786290
$4,131.96
in general payments reported to CMS, 2019-2025
16 companies · $612 in 2025
The $612 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $421 · 2022: $1,328 · 2023: $749 · 2024: $1,022 · 2025: $612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,382.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $717.10 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Coopervision INC. | $659.95 | 2021-2025 | Myday Contact Lens, Misight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $519.59 | 2023-2025 | Acuvue |
| Alcon Vision LLC | $429.92 | 2022-2025 | Precision 1, Tryptyr, Simbrinza |
| Oyster Point Pharma, INC. | $399.43 | 2022-2023 | Tyrvaya |
| Eyevance Pharmaceuticals LLC | $289.20 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $245.63 | 2023 | Cequa |
| Glaukos Corporation | $245.63 | 2021-2022 | |
| Harrow Eye, LLC | $138.79 | 2024 | Vevye |
| Allergan, INC. | $125.00 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $111.39 | 2024-2025 | Xdemvy |
| Abbvie INC. | $73.68 | 2022 | |
| Kala Pharmaceuticals, INC. | $66.38 | 2022 | |
| Horizon Therapeutics Plc | $54.34 | 2023 | Tepezza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $35.79 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $20.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Sutnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.